Dublin, Aug. 13, 2018 (GLOBE NEWSWIRE) -- The "Modular Facilities in Pharmaceutical/Biotechnology Industry, 2017-2030" report has been added to ResearchAndMarkets.com's offering.

The Modular Facilities in the Pharmaceutical/Biotechnology Industry, 2017-2030' report provides an extensive study on the current market landscape and future outlook of modular facility manufacturers that cater to the demands of pharmaceutical and biopharmaceutical companies. The study presents an in-depth analysis of a diverse set of companies that provide complete modular facilities and/or modular cleanrooms to drug researchers/developers.

It has been reported that the time required for the construction of modular facilities, starting from design to approval, could be reduced to half the time required for the construction of conventional facilities. This is primarily due to the fact that modular buildings (modules) are typically constructed offsite, transported to the site and then assembled into fully functional entities. As a consequence of the approach used, facility construction, site preparation and regulatory documentation can proceed in parallel. This is very different from the traditional approach where the aforementioned activities have to be performed sequentially.

In addition to other elements, the report features:

• A review of the competitive market landscape of modular facility/modular cleanroom manufacturers with information on their geographical location (North America, Europe, Asia Pacific and rest of the world), establishment year, size (small-sized, mid-sized or large-sized) and type of industries served (pharmaceutical, biotechnology or others). It also includes information on regulatory certifications and recent projects undertaken by these companies.
• Elaborate profiles of established players that offer a wide range of modular manufacturing solutions to pharmaceutical and biotechnology industries; each profile includes a brief overview of the company, information on its financial status, comprehensive modular services portfolio, recent collaborations, information on capability/facility expansions and an informed future outlook.
• An analysis of the most active regions based on the locations of modular manufacturing solution providers; the report contains schematic representations of world maps that clearly indicate the modular facility/cleanroom manufacturing hubs.
• A review of emerging trends, including the combination of single use technologies/continuous processing technologies with modular facilities, the shift to using smaller, multi-purpose and multi-product modular facilities.
• A discussion on key points that should be considered to facilitate the shift from using conventional facilities to modular facilities. We have provided a case study on JHL Biotech's KUBio biomanufacturing facility, which was constructed by GE Healthcare Life Sciences in China.
• A detailed discussion on the various growth drivers, such as the development of personalized medicines, biosimilars, orphan drugs, and the anticipated increase in adoption of modular solutions in emerging markets and by pharmaceutical/biopharmaceutical CMOs.
• A detailed analysis of the collaborations and agreements, covering facility construction agreements, service alliances and acquisitions, which have been established amongst various stakeholders in the past few years.

The study features a detailed analysis on the likely evolution of the pharmaceutical/biotechnology modular manufacturing market over the time period 2017 to 2030. We have provided insights on the expected growth of the market in different regions, including North America, Europe, Asia Pacific and rest of the world. In addition, we have segmented the likely evolution of the market on the basis of type of construction component (process equipment, base building, mechanical, electrical, process utilities, process piping and others), size of the facility (small-sized, mid-sized and large-sized), type of product (small molecules, biologics and others), purpose of facility (manufacturing facility, R&D facility and others) and type of facility (new facility and expansions). In order to account for the uncertainties associated with some of the parameters used and to add robustness to our model, we have presented three different forecast scenarios, depicting conservative, base and optimistic tracks of the market's evolution.

The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. Actual figures have been sourced and analyzed from publicly available data. The opinions and insights presented in the report were also influenced by discussions with senior stakeholders in the industry.

The report presents detailed transcripts of discussions held with Maik Jornitz (CEO, G-CON Manufacturing), Pr Almhem (President, ModWave), Sulogna Roy (Sales Manager/Project Manager, Zeton) and Vernon Solomon (President, Environmental Systems Corporation).

Example Highlights

1. During the course of our study, we identified close to 20 companies that offer modular facilities to pharmaceutical/biotechnology industry. Majority of these companies are located in North America and Europe. Examples of players based in these regions include (in alphabetical order) Biologics Modular, G-CON Manufacturing, GE Healthcare Life Sciences, Germfree Laboratories, IPM Technologies, Jacobs Engineering Group, KeyPlants, ModWave, NNE, Pharmadule Morimatsu and WH Partnership.

2. In addition, there are a number of players that specialize in providing modular cleanrooms; during our research, we identified more than 160 such companies. Of these, there are several companies that solely focus on serving the pharmaceutical and biotechnology industries; examples include (in alphabetical order, no specific shortlisting criteria) American Cleanroom Systems, Asgard Cleanroom Solutions, AWS BIO PHARMA Technologies, CID Associates, Clean Air Flow, Clean Room Depot, Environmental Systems Corporation, Modulus Cleanrooms and Shanghai HJ Modular Cleanroom.

3. Several pharmaceutical and biotechnology companies have adopted the modular concept for constructing new facilities or expanding existing infrastructure. Examples of some established companies include (in alphabetical order) AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Pfizer, Merck, Roche, Novartis and Sanofi. Additionally, small to mid-sized companies that have installed modular facilities include (in alphabetical order) 3P Biotherapeutics, JHL Biotech, Just Biotherapeutics, Stragen Pharma and Strike Bio. In fact, in May 2016, JHL Biotech inaugurated a 2,400 square meters new manufacturing facility, based on the modular KUBio platform of GE Healthcare Sciences, at its site in Wuhan, China. More recently, in March 2017, Just Biotherapeutics contracted G-CON Manufacturing for the construction of a cGMP biologics facility in the Hangzhou Economic and Technology Development Area (HEDA) in China. The facility is currently under construction and is anticipated to be completed and operational in early 2018.

4. A number of strategic collaborations have been inked in this domain. We came across over 35 collaborations established during the period 2014-H12017. Majority (~80%) of these collaborations are facility construction agreements. Prominent pharmaceutical/biotechnology modular facility or cleanroom providers that have entered into multiple partnerships include G-CON Manufacturing, GE Healthcare Life Sciences, AES Technology, M+W Group, and Pharmadule Morimatsu.

5. Companies manufacturing niche and emerging therapeutic classes, such as personalized therapies, along with the rising number of biosimilars, hold significant promise for modular facility manufacturers. The adoption of such facilities is also likely to increase in emerging regions, some of which have struggled to meet GMP standards. In addition, CMOs, adopting modular facilities to reduce initial capital investment and handle multiple products, are expected to create incremental business opportunities for modular facility manufacturers.

6. The pharmaceutical/biotechnology modular facilities market is anticipated to grow at an annualized rate of 8.9% during the period 2017-2030. Modular facilities for biologics manufacturing are expected to dominate (with more than 80% share) the market. Further, 85% of the overall market share is accounted for by facilities being used for manufacturing purposes. This is followed by facilities for R&D applications (12% of the overall market). In terms of type of facility, the opportunity is likely to be driven by construction of new facilities (65%) followed by modular expansions projects that will likely account for the remaining 35% of the market's share.

Companies Mentioned

• 209 Technologies
• A&M Project Services
• AASTHA CLEANROOM SYSTEMS
• ABN Cleanroom Technology
• Abtech
• ACH Engineering
• Acumen Technology
• A.D. Cleanrooms Engineering
• ADDvise
• AES Clean Technology
• Air Innovations
• Airgas
• Airology
• Air Micron Cleantech
• Aircare Projects
• Airtech Systems
• AJNI Industries
• Ajinomoto North America
• AKERTEC
• Albian Group
• Alembic Pharmaceuticals
• Allied Cleanrooms
• Alnylam Pharmaceuticals
• AME For Industry
• AM Cleanroom Build and Performance
• American Cleanroom Systems
• Angstrom Technology
• Aqvida
• Arthrex
• Asgard Cleanroom Solutions
• AstraZeneca
• AWS BIO PHARMA TECHNOLOGIES
• Axenic Systems
• Bangalore Air Tech Solution
• Bassaire
• Baxter
• bc-technology
• Belcher Equipment
• Bode Equipment
• BioCon Solutions
• Biogen
• Bigneat
• Bioinspection
• Biologics Modular
• Biosoft
• Bouygues Energies & Services
• Bristol-Myers Squibb
• Broad Sustainable Building
• Butler Manufacturing
• Cambridge Cleanroom
• CID Associates
• Cipharm
• Clean Air Flow
• Clean Air Products
• Clean Air Systems
• Clean Air Technology
• Clean Modules
• Cleanrooms Australia
• Cleanroom Equipment
• Cleanroom Solutions
• ClearSphere
• Clean Room Depot
• Clean Rooms International
• Clean Rooms Plus
• Clean Rooms West
• Clean Zone Technology
• CleanAir Solutions
• Cleanroom Ceiling Systems (a division of Varni Enterprises)
• Cleanroom Results
• Cleanroom Synergy
• Cleanrooms By United
• CleanZones
• CLEEMS
• Clestra Cleanroom
• Cook Imaging
• Connect 2 Cleanrooms
• CONSAB International
• CRB Consulting Engineers
• Design Filtration Microzone
• Dortek Hygienic Doors
• Dr. Reddy's Laboratories
• Dynamic Manufacturing Solutions
• Ebtech Industrial Modular Building Solutions
• Eli Lilly
• E- Pack Polymers
• Enbloc
• Environmental Systems Corporation
• Envair Electrodyne
• Fabtech Technologies International
• Filtration Technology
• Firmament Technology
• Florida Cleanroom Systems
• Foothills Systems
• Flowstar
• Fluor
• Galderma
• Guardtech Cleanrooms
• G-CON Manufacturing
• GE Healthcare Life Sciences
• Genentech
• Gerbig Engineering Company
• Germfree Laboratories
• Gilcrest Manufacturing
• GlaxoSmithKline
• Glowmax Engineers
• GMP Technical Solutions
• GMPMax Pharma
• Green Carrier Consultancy and Tech Solutions
• Halco Products
• Hectra Enviro Systems
• Hemair Systems
• HEMCO Corporation
• HEPAire Products Corporation
• Hermetel Oy
• Hodess Construction
• Huntair
• Iberconcept
• Innclose
• Innotech Products
• Innovative Cleanroom Technologies
• InPlant Offices
• Instaspace
• Integrated Clean Room Technologies
• IPM Technologies
• Isoflex Systems
• IsoTech Design
• Jacobs Engineering Group
• JHL Biotech
• JMC Project Services
• Just Biotherapeutics
• KABTech Corporation
• KeyPlants
• Kingspan
• Kleantech Engineering Systems
• KTEC Cleanroom Systems
• Labard Instruchem
• Labover
• Labworks International
• Lasco Services
• Lennox Clean Room Technologies
• Liberty Industries
• LifeTek Solutions
• LM Air Technology
• Longden Company
• Lonza
• Mabion
• Mach-Aire
• MAK Clean Air Systems
• Mallinckrodt Pharmaceuticals
• Mars Sterile Solutions
• McDonald's
• MDI
• MECART
• Medipharma
• Merck
• Merit Holdings
• Microbinc
• Microzone Corporation
• MK Precision
• Moduclean
• Mobius Controlled Environments
• Modubuild
• Modulus Cleanrooms
• Modular Cleanrooms
• ModWave
• Monmouth Scientific
• Morimatsu Industry Group
• M P Prime Structures
• MRC Systems
• MTX Contracts
• M+W Group
• Nano Clean
• National Partitions
• NextCell Pharma
• NGS Cleanroom Solutions
• Nicomac
• NNE
• Norwood Group
• Novartis
• Novo Nordisk
• Octapharma
• OCTANORM
• OSB Prefab Technologies
• Pacific Environmental Technologies
• Panel Built
• Parteco
• PC Company
• Pfizer
• PermaTherm
• Pharmacia
• Pharmacon
• Pharmadule Morimatsu
• Pharmintech Turnkey Solutions
• Plascore
• Poppleton
• PortaFab
• Porta-King Building Systems
• Power And Motion
• Precision Air Technology
• Precision Cleanrooms
• Precision Engineering design
• ProCleanroom
• Progenitor Cell Therapy
• QleanAir Scandinavia
• Riddhi Metals
• Rinac India
• Robert Soper
• Sartorius Stedim Biotech
• Sapphire Cleanrooms
• Sears Roebuck and Company
• SCHILLING ENGINEERING
• Schering-Plough
• Shanghai HJ Modular Cleanroom
• SRS Shelving + Rack Systems
• Skylark Engineering Technologies
• Simplex Isolation Systems
• SML Clean Room Solutions
• Solutions and Handling
• Span Construction and Engineering
• Srprefabs Modular Cleanroom
• Starrco
• Stefatos
• Sterlitech
• Stevenage BioScience Catalyst
• Stodec Products
• SUNBEL
• Suntec Teknopak
• Stragen Pharma
• Swedish Modules
• Synergy Thrislington
• SZ Airkey Environmental Tech & Eng
• Tabuk Pharmaceuticals
• TCM (The Cleanroom Market)
• Technical Air Products
• Ted Thorsen Material Handling
• Telstar Life Science Solutions
• Termovent
• Terra Universal
• Teruisi Pharmaceutical
• Teva Pharmaceutical
• The Softwall Shop
• Travis Clean Air
• Tudela International
• Turnkey Modular Systems
• Ultrapure Technology
• United BioPharma
• United Partition Systems
• United Pharmaceuticals
• University of Tennessee Health Science Center
• Vanguard Modular Building Systems
• Vernick & Associates
• VRP CLEAN ROOM SYSTEMS
• Weaver Technologies
• Westbury Cleanrooms
• Western Environmental Corporation
• Whitenair Technologies
• WH Partnership
• w.w. Cannon
• XBiotech
• XCounter
• Xytel
• YRS Enterprises
• Zeton

For more information about this report visit https://www.researchandmarkets.com/research/dcbp3n/modular?w=12